Several authors described altered H19 expression in cardiovascular diseases and related it with hypertrophic growth inhibition in cardiomyocytes and alleviation of myocardial ischemia reperfusion injury [51,52,53]. The gene discussed is H19; the disease is cardiovascular disorder.